The rapid growth of electronic cigarette users has been felt by the British company GlaxoSmithKline (GSK) who produce nicotine patches and gum a chief executive said.
During the interview with Reuters, Andrew Witty admitted that he and his team had spend “a few days” in deciding on whether it would be the right decision for them to embrace the modern times and compete directly by creating electronic cigarettes of their own.
After careful consideration they decided that they “we’re not going to play”, and leave the e cig market well alone. Andrew Witty went on to say,
“Of course, it’s definitely taken a bit of our market, no question at all — but there’s a lot of competition in that space anyway.”
GSK are currently undergoing a joint venture with Novartis which will make the business the market leader in the smoking cessation market.
Read More Here: